18 October 2023: ADR Regulation on the Transport of Dangerous Goods
22 September 2023: How to move according with the Biocides Regulation
In a judgment delivered on Thursday, April 20, 2023, the Court of Justice of the European Union annulled the European Commission’s decision granting an authorization for certain uses of Chromium Trioxide under the REACH regulation governing the authorisation of chemicals in the EU.
ECHA published an overview of the dates when evaluating competent authorities are planning to submit assessment reports for biocidal active substance approvals or renewals from eCA to ECHA for opinion forming of the Biocidal Products Committee (BPC) of the Agency.
We would like to inform you that the provision to revoke the marketing authorizations of PMC products intended for the disinfection of intact skin before medical treatment has been adopted.
In April, ECHA recommended to the European Commission the inclusion of 8 SVHC substances in the authorization list, based on the prioritization supported by the opinion of the Member State Committee.
We would like to point out that ECHA has organized a webinar that feature several tools and initiatives supporting stakeholders in the process of moving to safer alternatives, as the topic of substitution and analysis of alternatives of the most hazardous biocidal active substances is of growing interest.
We would like to point out that on March 24, the Implementing Regulation (EU) 2023/680, approving Alkyl dimethylbenzyl ammonium chloride as an active substance for use in biocidal products of product-type 1 in accordance with Regulation (EU) No 528/2012 (BPR), was published on the Official Journal of the European Union.
ECHA has recently published the “multiannual work programme / strategic plan for 2023-2026” which aims to provide an overview of the activities, objectives and human and financial resources allocated for delivering these projects in 2023 and an outlook until 2026.
Has your company registered the substance 2-furaldehyde (CAS 98-01-1) or 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran (CAS 1222-05-5)?